CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -28.6% | 697 | 0.0% | 0.00% | – |
| Q2 2023 | $7 | -85.4% | 697 | -89.9% | 0.00% | – |
| Q1 2023 | $48 | +41.2% | 6,912 | +21.4% | 0.00% | – |
| Q4 2022 | $34 | -99.9% | 5,692 | -7.8% | 0.00% | – |
| Q3 2022 | $49,000 | -44.3% | 6,171 | -4.3% | 0.00% | -100.0% |
| Q2 2022 | $88,000 | +700.0% | 6,450 | +1083.5% | 0.00% | – |
| Q1 2022 | $11,000 | -42.1% | 545 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -93.5% | 545 | -86.4% | 0.00% | -100.0% |
| Q2 2021 | $294,000 | -10.1% | 4,006 | +12.2% | 0.00% | 0.0% |
| Q1 2021 | $327,000 | – | 3,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |